BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gandhi P, Shrivastava R, Garg N, Sorte SK. Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients . World J Clin Oncol 2021; 12(10): 947-959 [PMID: 34733616 DOI: 10.5306/wjco.v12.i10.947]
URL: https://www.wjgnet.com/2218-4333/full/v12/i10/947.htm
Number Citing Articles
1
Michael Goutnik, Brandon Lucke-Wold. Commentary: Evaluating potential glioma serum biomarkers, with future applicationsWorld Journal of Clinical Oncology 2022; 13(5): 412-416 doi: 10.5306/wjco.v13.i5.412
2
Rongxuan Hua, Qiuxuan Li, Han Gao, Boya Wang, Chengwei He, Ying Wang, Sitian Zhang, Lei Gao, Hongwei Shang, Wen Wang, Jingdong Xu. Association of human telomerase reverse transcriptase promoter mutation with unfavorable prognosis in glioma: A systematic review and meta-analysisJournal of Research in Medical Sciences 2023; 28(1) doi: 10.4103/jrms.jrms_371_22
3
Jyoti Kiran Bara, Puneet Gandhi, Pramod Verma. Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experienceActa Diabetologica 2024;  doi: 10.1007/s00592-024-02398-8
4
Richa Shrivastava, Puneet Gandhi, Sandeep K. Sorte, Adesh Shrivastava. Characterizing the Linkage of Systemic Hypoxia and Angiogenesis in High-Grade Glioma to Define the Changes in Tumor Microenvironment for Predicting PrognosisJournal of Molecular Neuroscience 2024; 74(3) doi: 10.1007/s12031-024-02240-4
5
Richa Shrivastava, Puneet Gandhi, Ragini Gothalwal. The road-map for establishment of a prognostic molecular marker panel in glioma using liquid biopsy: current status and future directionsClinical and Translational Oncology 2022; 24(9): 1702 doi: 10.1007/s12094-022-02833-8